stoxline Quote Chart Rank Option Currency Glossary
  
Stereotaxis, Inc. (STXS)
1.91  -0.03 (-1.55%)    06-13 16:00
Open: 1.93
High: 1.98
Volume: 185,443
  
Pre. Close: 1.94
Low: 1.9
Market Cap: 158(M)
Technical analysis
2024-06-13 4:46:33 PM
Short term     
Mid term     
Targets 6-month :  2.44 1-year :  2.63
Resists First :  2.09 Second :  2.25
Pivot price 1.95
Supports First :  1.83 Second :  1.52
MAs MA(5) :  1.95 MA(20) :  1.98
MA(100) :  2.42 MA(250) :  1.94
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  34.7 D(3) :  39
RSI RSI(14): 37.1
52-week High :  3.28 Low :  1.33
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ STXS ] has closed above bottom band by 22.8%. Bollinger Bands are 74.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.98 - 2 2 - 2.01
Low: 1.88 - 1.89 1.89 - 1.91
Close: 1.89 - 1.91 1.91 - 1.93
Company Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

Headline News

Thu, 06 Jun 2024
Stereotaxis Inc. (STXS) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Canada Shine On

Thu, 30 May 2024
Insider Buying: Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Acquires 6,000 Shares of Stock - MarketBeat

Mon, 27 May 2024
Stereotaxis (STXS) Gets CE Recertification for Approved Products - Yahoo Finance

Fri, 24 May 2024
Stereotaxis' (STXS) RMN System to Aid in Treating Arrhythmias - Yahoo Finance

Thu, 23 May 2024
Stereotaxis Makes A Strategic Acquisition Bolstering Its Future (NYSE:STXS) - Seeking Alpha

Wed, 15 May 2024
Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 81 (M)
Shares Float 47 (M)
Held by Insiders 14.9 (%)
Held by Institutions 49 (%)
Shares Short 723 (K)
Shares Short P.Month 1,790 (K)
Stock Financials
EPS -0.28
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.23
Profit Margin -67.2 %
Operating Margin -72.4 %
Return on Assets (ttm) -26.1 %
Return on Equity (ttm) -68.8 %
Qtrly Rev. Growth 1.8 %
Gross Profit (p.s.) 0.22
Sales Per Share 0.36
EBITDA (p.s.) -0.26
Qtrly Earnings Growth 0 %
Operating Cash Flow -9 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -7.08
PEG Ratio 0
Price to Book value 8.3
Price to Sales 5.23
Price to Cash Flow -16.71
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android